Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schuler

Showing results (31-40 of 296) with videos related to

Pageof 30
Sort By:
Journal of Cancer Research and Clinical Oncology|April 11, 2012
Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancerJohannes Meiler, Melanie Guyot, Sandra Hoffarth, et al.
International Journal of Cancer|August 11, 2007
Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancerEmmanuelle Wesarg, Sandra Hoffarth, Rainer Wiewrodt, et al.
Interactive Cardiovascular and Thoracic Surgery|July 5, 2012
Growth patterns of lung metastases from sarcoma: prognostic and surgical implications from histologyStefan Welter, Florian Grabellus, Sebastian Bauer, et al.
Cancers|August 27, 2021
Lung Cancer Surgery after Neoadjuvant ImmunotherapyDirk Stefani, Till Plönes, Jan Viehof, et al.
European Urology|June 30, 2009
Therapeutic potential of Mdm2 inhibition in malignant germ cell tumoursSebastian Bauer, Thomas Mühlenberg, Michael Leahy, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2019
Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesotheliomaPaul Stockhammer, Till Ploenes, Dirk Theegarten, et al.
Plos One|March 18, 2015
Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumorThomas Mühlenberg, Susanne Grunewald, Jürgen Treckmann, et al.
Annals of Hematology|August 10, 2006
Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphomaGeorg Hess, Thomas Flohr, Karin Kolbe, et al.
Studies in Health Technology and Informatics|August 8, 2025
Evaluating Zero-Shot Foundation Models for Time Series Forecasting in Clinical Settings: A Simulation Study with Electronic Health RecordsGernot Pucher, Amin Dada, Felix Nensa, et al.
Blood|August 12, 2008
Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosisClaudia Stolz, Georg Hess, Patricia S Hähnel, et al.
Pageof 30

Showing results (31-40 of 296) with videos related to

Sort By:
Pageof 30
Journal of Cancer Research and Clinical Oncology|April 11, 2012
Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancerJohannes Meiler, Melanie Guyot, Sandra Hoffarth, et al.
International Journal of Cancer|August 11, 2007
Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancerEmmanuelle Wesarg, Sandra Hoffarth, Rainer Wiewrodt, et al.
Interactive Cardiovascular and Thoracic Surgery|July 5, 2012
Growth patterns of lung metastases from sarcoma: prognostic and surgical implications from histologyStefan Welter, Florian Grabellus, Sebastian Bauer, et al.
Cancers|August 27, 2021
Lung Cancer Surgery after Neoadjuvant ImmunotherapyDirk Stefani, Till Plönes, Jan Viehof, et al.
European Urology|June 30, 2009
Therapeutic potential of Mdm2 inhibition in malignant germ cell tumoursSebastian Bauer, Thomas Mühlenberg, Michael Leahy, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2019
Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesotheliomaPaul Stockhammer, Till Ploenes, Dirk Theegarten, et al.
Plos One|March 18, 2015
Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumorThomas Mühlenberg, Susanne Grunewald, Jürgen Treckmann, et al.
Annals of Hematology|August 10, 2006
Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphomaGeorg Hess, Thomas Flohr, Karin Kolbe, et al.
Studies in Health Technology and Informatics|August 8, 2025
Evaluating Zero-Shot Foundation Models for Time Series Forecasting in Clinical Settings: A Simulation Study with Electronic Health RecordsGernot Pucher, Amin Dada, Felix Nensa, et al.
Blood|August 12, 2008
Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosisClaudia Stolz, Georg Hess, Patricia S Hähnel, et al.
Pageof 30